176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-26.70%
Revenue decline while TSM shows 14.09% growth. Joel Greenblatt would examine competitive position erosion.
-12.71%
Cost reduction while TSM shows 5.04% growth. Joel Greenblatt would examine competitive advantage.
-52.07%
Gross profit decline while TSM shows 39.32% growth. Joel Greenblatt would examine competitive position.
-34.61%
Margin decline while TSM shows 22.11% expansion. Joel Greenblatt would examine competitive position.
9.02%
R&D growth 50-75% of TSM's 12.11%. Bruce Berkowitz would examine spending effectiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-62.88%
Other expenses reduction while TSM shows 0.00% growth. Joel Greenblatt would examine efficiency.
3.52%
Operating expenses growth less than half of TSM's 28.48%. David Dodd would verify sustainability.
-9.58%
Total costs reduction while TSM shows 8.01% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
9.66%
D&A growth less than half of TSM's 25.46%. David Dodd would verify if efficiency is sustainable.
-95.26%
EBITDA decline while TSM shows 31.55% growth. Joel Greenblatt would examine position.
-78.77%
EBITDA margin decline while TSM shows 6.47% growth. Joel Greenblatt would examine position.
-94.74%
Operating income decline while TSM shows 46.68% growth. Joel Greenblatt would examine position.
-92.82%
Operating margin decline while TSM shows 28.56% growth. Joel Greenblatt would examine position.
-22.59%
Other expenses reduction while TSM shows 67.35% growth. Joel Greenblatt would examine advantage.
-93.69%
Pre-tax income decline while TSM shows 101.80% growth. Joel Greenblatt would examine position.
-91.39%
Pre-tax margin decline while TSM shows 76.88% growth. Joel Greenblatt would examine position.
-93.69%
Tax expense reduction while TSM shows 299.31% growth. Joel Greenblatt would examine advantage.
-93.69%
Net income decline while TSM shows 84.96% growth. Joel Greenblatt would examine position.
-91.39%
Net margin decline while TSM shows 62.11% growth. Joel Greenblatt would examine position.
-93.48%
Both companies show declining EPS. Martin Whitman would check industry conditions.
-92.31%
Both companies show declining diluted EPS. Martin Whitman would check industry conditions.
1.07%
Share count reduction exceeding 1.5x TSM's 8.56%. David Dodd would verify capital allocation.
-7.56%
Diluted share reduction while TSM shows 8.56% change. Joel Greenblatt would examine strategy.